| Active substance |
Telmisartan |
| Also known as |
Pritor, Kinzalmono |
| Blood pressure |
Reduces systolic and diastolic blood pressure |
| Chemical name |
4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid |
| Dosage (medical) |
Typically 20-80 mg once daily |
| Dosage (sports) |
Not applicable as not typically used for performance enhancement |
| Effects |
Lowers blood pressure, reduces strain on the heart |
| FORM |
28 pills x 80 mg |
| Formula |
C33H30N4O2 |
| Half-life |
24 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Blood pressure monitoring, renal function tests |
| Main action |
Antihypertensive, blocks angiotensin II receptors |
| Side effects |
Dizziness, hypotension, fatigue, diarrhea, upper respiratory tract infections |
| Storage conditions |
Store at room temperature, protect from moisture and light |
| Substance class |
Angiotensin II receptor antagonist |
| Trade name |
Micardis |
| Use in sports |
Not commonly used in sports |
| Water Retention |
Low risk |
| Manufacturer |
Boehringer |
